Skip to content
  • Sunday, 26 July 2026
  • 2:59 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Top Pharma Companies Set Sustainability Goals, But Emissions Are Still Increasing
Laboratory Automation & Robotics

Top Pharma Companies Set Sustainability Goals, But Emissions Are Still Increasing

Lana Keisha Jul 3, 2026 0

The global healthcare industry, a cornerstone of human well-being, paradoxically carries a substantial environmental burden, contributing an estimated 4.4% of…

Read More
Pharmaceutical R&D

Seven Pharma Companies Selected for FDA PreCheck Pilot Program to Bolster U.S. Drug Supply Chain

Teuku Ryan Jun 30, 2026 0

The U.S. Food and Drug Administration (FDA) has announced the initial cohort of seven pharmaceutical companies selected to participate in…

Read More
Laboratory Automation & Robotics

Top pharma companies set sustainability goals, but emissions are still increasing

Lana Keisha Jun 26, 2026 0

The global healthcare industry, a cornerstone of human well-being and longevity, is simultaneously a significant contributor to the planet’s environmental…

Read More
Laboratory Automation & Robotics

Top pharma companies set sustainability goals, but emissions are still increasing.

Lana Keisha Jun 17, 2026 0

The global healthcare industry, a cornerstone of human well-being, faces a profound paradox: while dedicated to improving health, its operational…

Read More
Laboratory Automation & Robotics

Top Pharma Companies Set Sustainability Goals, But Emissions Are Still Increasing

Lana Keisha May 30, 2026 0

The healthcare industry, a cornerstone of global well-being, paradoxically contributes an estimated 4.4% of total global emissions annually, placing it…

Read More
Laboratory Automation & Robotics

Top pharma companies set sustainability goals, but emissions are still increasing

Lana Keisha May 23, 2026 0

The global healthcare industry stands as a significant contributor to the planet’s carbon footprint, accounting for an estimated 4.4% of…

Read More
Pharmaceutical R&D

Apotex Acquires Cumberland Pharmaceuticals’ Branded Drug Portfolio for $100 Million, Ushering in New Era for Both Companies

Teuku Ryan Apr 26, 2026 0

Canadian pharmaceutical giant Apotex has announced a significant strategic acquisition, agreeing to purchase Cumberland Pharmaceuticals’ entire portfolio of branded commercial…

Read More
Pharmaceutical R&D

Cochrane Review Challenges Clinical Significance of Anti-Amyloid Alzheimer’s Drugs, Pharmaceutical Companies Reaffirm Efficacy

Teuku Ryan Apr 18, 2026 0

A comprehensive review of 17 clinical trials by the esteemed Cochrane organization has cast doubt on the clinically meaningful benefits…

Read More
A decade in the making: How functional NAMs are redefining cardiac safety assessmentUnderstanding Osteopenia: The Global Silent Epidemic of Bone Density Loss and the Path to PreventionInsilico CEO sees potentially $2.75 billion collaboration as ‘fusing Lilly’s clinical excellence’ with Insilico’s ‘end-to-end AI engine’RIKEN Physicists Pioneer Robust Nonreciprocal Quantum Synchronization for Phonons Overcoming Environmental Noise and Manufacturing Imperfections
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ